State Street Corp Clene Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.95 - $1.62 $57,000 - $97,200	60,000 Added 88.18%	128,046 $144,000
Q2 2022 Aug 15, 2022	SELL	$2.1 - $4.12 $1.76 Million - $3.44 Million	-835,839 Reduced 92.47%	68,046 $171,000
Q1 2022 May 16, 2022	BUY	$2.42 - $4.42 $49,917 - $91,171	20,627 Added 2.34%	903,885 $3.56 Million
Q4 2021 Feb 14, 2022	BUY	$3.95 - $7.53 $1.95 Million - $3.72 Million	493,581 Added 126.66%	883,258 $3.62 Million
Q3 2021 Nov 15, 2021	BUY	$6.83 - $13.58 $758,526 - $1.51 Million	111,058 Added 39.86%	389,677 $2.66 Million
Q2 2021 Aug 16, 2021	BUY	$6.98 - $13.33 $1.94 Million - $3.71 Million	278,619 New	278,619 $3.13 Million

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.